We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

DIASYS DIAGNOSTIC SYSTEMS

Develops, manufactures, and distributes diagnostic systems for clinical chemistry and immunoturbidimetry. Supplies hi... read more Featured Products: More products

Download Mobile App





DiaSys Showcases High Quality Clinical Chemistry Solutions at WHX Labs Dubai

By LabMedica International staff writers
Posted on 10 Feb 2026

At WHX Labs Dubai 2026, DiaSys Diagnostic Systems GmbH (Holzheim, Germany) is presenting a comprehensive portfolio of diagnostic solutions focused on clinical chemistry and immunoturbidimetry. More...

Exhibiting at booth S2.E50, the company highlights more than three decades of experience supplying laboratories in over 140 countries worldwide. Visitors to the company's booth can experience live demonstrations and learn about DiaSys's latest innovations that support laboratories throughout the world.

At its booth, DiaSys showcases its instrumentation portfolio of automated clinical chemistry analyzers that provide efficient and reliable testing options for small to medium-sized laboratories. This includes the respons® c-line series, featuring the respons® 240c, respons® 420c, and respons® 600c analyzers. In addition, the portfolio includes dedicated systems such as the respons® A1c for HbA1c testing and the respons® UDS100 for urine diagnostics.

DiaSys is also highlighting its broad portfolio of more than 90 ready-to-use reagents, spanning routine clinical chemistry, lipid testing, liver and kidney function, coagulation-related markers, inflammatory biomarkers, and specialized immunoturbidimetric assays. The reagent range is complemented by calibrators and controls, enabling complete, traceable, and quality-assured system solutions for clinical laboratories.

The portfolio is further supported by DiaSys’s TruCal® calibrators and TruLab® quality control materials, which support standardized workflows, traceability, and consistent analytical performance across clinical chemistry testing.

Related Links: 
DiaSys Diagnostic Systems

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
Steam Sterilizer
Hi Vac II Line
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers use a novel immobilized liposome-bound gel beads method to measure CEC levels and their association with cardiovascular risks (Photo courtesy of Institute of Science Tokyo)

Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features

Unstable coronary plaques are difficult to identify before they trigger acute cardiovascular events. Standard high-density lipoprotein (HDL) measurements do not always capture how well HDL particles function... Read more

Pathology

view channel
Image: Overview of the uncertainty-aware lensfree computational pathology platform for automated HER2 assessment. A compact lensfree holographic imaging system captures diffraction patterns from immunohistochemically stained breast tissue samples, which are computationally reconstructed and analyzed using deep neural networks with Bayesian uncertainty quantification. (Photo courtesy of Ozcan Lab, UCLA)

Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer

Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.